- Serotype Distribution and β-Lactam Resistance in Haemophilus influenzae Isolated from Patients with Respiratory Infections in Korea
-
Songmee Bae , Jaehoon Lee , Eunah Kim , Jaehwa Lee , Jaeyon Yu , Yeonho Kang
-
J. Microbiol. 2010;48(1):84-88. Published online March 11, 2010
-
DOI: https://doi.org/10.1007/s12275-009-0212-9
-
-
895
View
-
2
Download
-
3
Crossref
-
 Abstract
 PDF
-
Haemophilus influenzae is a frequent causative bacterial pathogen of respiratory tract infections. Resistance to β-lactam antibiotics has been a significant clinical problem in treatment for H. influenzae respiratory infections. This study describes the serotype, antibiotic resistance and distribution of TEM-1 or ROB-1 β-lactamase in H. influenzae isolates from local private hospitals from 2002 to 2004. Among the 100 H. influenzae respiratory isolates, only 7% were identified as serotypes a, b, e, and f, with the remaining 93% being nontypeable. Resistance to ampicillin, cefaclor, and tetracycline was 57%, 46%, and 16%, respectively. All strains were susceptible to azithromycin and ciprofloxacin, whereas amoxicillin/clavulanate, cefotaxime,
and imipenem exhibited reduced susceptibilities of 99%, 99%, and 91%, respectively. All 57 ampicillinresistant strains (minimum inhibitory concentration, MIC≥4 µg/ml) were β-lactamase-positive and possessed the TEM-1 type β-lactamase. One β-lactamase-positive amoxicillin/clavulanate-resistant isolate that was resistant to ampicillin (MIC>128 µg/ml) had the TEM-1 type β-lactamase and not susceptible to cefaclor and cefotaxime. Analysis of penicillin binding protein 3 revealed six residues (Asp-350, Met-377, Ala-502, Asn-526, Val-547, and Asn-569)that were substituted by Asn, Ile, Val, Lys, Ile, and Ser, respectively.
-
Citations
Citations to this article as recorded by  - Results from the Survey of Antibiotic Resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore
D. Torumkuney, R. Chaiwarith, W. Reechaipichitkul, K. Malatham, V. Chareonphaibul, C. Rodrigues, D. S. Chitins, M. Dias, S. Anandan, S. Kanakapura, Y. J. Park, K. Lee, H. Lee, J. Y. Kim, Y. Lee, H. K. Lee, J. H. Kim, T. Y. Tan, Y. X. Heng, P. Mukherjee, I
Journal of Antimicrobial Chemotherapy.2016; 71(suppl 1): i3. CrossRef - Haemophilus influenzae serotype a as a cause of serious invasive infections
Marina Ulanova, Raymond S W Tsang
The Lancet Infectious Diseases.2014; 14(1): 70. CrossRef - Global Epidemiology of Invasive Haemophilus influenzae Type a Disease: Do We Need a New Vaccine?
Marina Ulanova
Journal of Vaccines.2013; 2013: 1. CrossRef
|
MSK
